Lyka Labs Limited (LYKALABS) Financial History

Name: Lyka Labs Limited (LYKALABS) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-09-20

Lyka Labs Limited (LYKALABS) operates in the Biotechnology industry and is headquartered in Mumbai, India with about 648 employees. Its market capitalization is roughly ₹3 billion. In the fiscal year ended 2026-03-31, LYKALABS reported ₹1.3B in revenue and (₹100M) in net income.

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations for human and animal healthcare in India and internationally.

Interactive charts & full statements →

LYKALABS Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹1.3B	₹1.4B	₹1.1B	₹883M	—
Gross Profit	₹782M	₹829M	₹599M	₹505M	—
Operating Income (EBIT)	(₹121M)	₹112M	₹30M	₹28M	—
Net Income	(₹100M)	₹80M	(₹25M)	(₹132M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LYKALABS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹423M	₹280M	₹307M	₹367M	₹330M
Gross Profit	₹259M	₹170M	₹192M	₹218M	₹203M
Operating Income (EBIT)	₹25M	(₹85M)	(₹5M)	(₹47M)	₹16M
Net Income	₹21M	(₹76M)	₹0M	(₹34M)	₹9M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LYKALABS Free Cash Flow History

LYKALABS Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹1.7B	₹1.8B	₹1.6B	₹1.5B	—
Total Liabilities	₹837M	₹726M	₹886M	₹1.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LYKALABS viewer.

Other Companies in Biotechnology

2509 · Qyuns Therapeutics Co., Ltd. — HK$4 billion
2629 · Mirxes Holding Company Limited — HK$4 billion
6826 · Shanghai Haohai Biological Technology Co., Ltd. — HK$4 billion
GPCR · Structure Therapeutics Inc. — $3 billion
2105 · Laekna, Inc. — HK$3 billion
BION · BB Biotech AG — CHF 3 billion
1875 · BioDlink International Company Limited — HK$3 billion
2197 · Clover Biopharmaceuticals, Ltd. — HK$3 billion

← LYG All “L” companies LYLD →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.